Affordable Access

Down's syndrome and mixed acute leukemia in infants.

Authors
  • Penchansky, L
  • Kaplan, S S
  • Stolc, V
  • Krause, J R
Type
Published Article
Journal
Cancer
Publication Date
Jul 15, 1991
Volume
68
Issue
2
Pages
414–417
Identifiers
PMID: 1829979
Source
Medline
License
Unknown

Abstract

The routine use of panels of monoclonal antibodies has been complementary to the French-American-British (FAB) leukemia classification, and has unmasked the occurrence of mixed acute leukemia (myeloid-lymphoid). It is widely accepted that children with Down's syndrome (DS) have a high incidence of acute leukemia. There is an extensive body of literature emphasizing the cytogenetic findings in these children. However, information as to the immunophenotype is often limited to the lymphoid surface determinants. The authors report two children with DS whose leukemic blasts were studied with a panel of 17 monoclonal antibodies (myeloid, lymphoid, and megakaryocytic) by flow cytometric examination and were classified as biphenotypic acute leukemia. The blast population coexpressed myeloid and T-cell surface markers. The lymphoid origin was ruled out on the basis of negative terminal deoxynucleotidyl transferase and molecular analysis demonstrating germline configuration for the JH and beta TCR genes.

Report this publication

Statistics

Seen <100 times